Stocks Surging: Celebrating the Rise of Micron, Iris Energy, and More on a Jubilant Monday

Avatar photo

U.S. stocks experienced a dip, witnessing the Dow Jones tumble by approximately 250 points this Monday.

Micron Technology Delight

Micron Technology, Inc.’s shares soared magnificently during Monday’s trading as B of A Securities bestowed a Buy rating on the stock while lifting its price target from $120 to $144, propelling Micron Technology shares up by 6.6% to a price of $125.69.

Other Stocks Shining Bright

Several other significant stocks followed the upward trajectory, including:

  • Doma Holdings Inc. surged by 34% to $6.08 after announcing a merger deal with TRG to go private at $6.29 per share.
  • Mesoblast Limited gained 22.4% to $6.13 following encouraging FDA feedback on its Phase 3 study MSB-GVHD001.
  • SolarMax Technology, Inc. rose by 22.1% to $11.18.
  • Ouster, Inc. saw its shares jump by 19.8% to $9.51.
  • Jiuzi Holdings, Inc. climbed 17.2% to $4.09.
  • Ballard Power Systems Inc. gained 16.4% to $3.2350 following the announcement of a significant Long Term Supply Agreement.
  • Iris Energy Limited elevated by 16% to $6.26 as Cantor Fitzgerald reiterated its position on the stock with an Overweight rating and a $10 price target.
  • Allego N.V. rose by 15.2% to $1.67.
  • GigaCloud Technology Inc. saw a rise of 13.3% to $30.26.
  • ZimVie Inc. experienced a jump of 12.6% to $18.56 after closing a lucrative business deal.
  • DouYu International Holdings Limited rose by 12% to $7.38.
  • COMPASS Pathways plc advanced by 10.6% to $9.20 after receiving an Overweight rating and a new price target from Morgan Stanley.
  • Coeur Mining, Inc. saw a rise of 9.6% to $4.1350.
  • Trip.com Group Limited climbed by 7.6% to $47.24 with a revised price target from Citigroup.
  • NexGen Energy Ltd. grew by 7% to $8.31.
  • Western Digital Corporation saw a rise of 5.7% to $72.13.
  • The Chemours Company experienced a growth of 6.4% to $27.94.

 

Keen to dive deeper? Check out the latest on insiders buying Outlook Therapeutics and two other stocks.

Benzinga makes investing smarter and simpler.

Get expert insights, analyst ratings, free reports, and breaking news to navigate the stock market confidently.


5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.

The free Daily Market Overview 250k traders and investors are reading

Read Now